Zomma Group

Catalyst Pharmaceutical Partners is a specialty pharmaceutical company that is focused on the development and commercialization of prescription drugs for the treatment of addiction. The company undertakes research and development activities in the area of developing the molecule vigabatrin, which is used in the treatment for addiction to cocaine, amphetamines and other addictive substances. Its product candidate based on vigabatrin is CPP-109, which has been granted fast-track status by the Food and Drug Administration for the treatment of cocaine addiction. The company has an on-site laboratory and a staff of trained professionals. It has also conducted human clinical trials of CPP-109. The company is located in Coral Gables, Fla.

SpecialtiesAppelrouth Farah & Co. is a full service accounting and international business advisory firm specializing in auditing, domestic and international taxation, litigation support, forensic accounting, fraud examination, business valuation and family office. The firm was founded in 1985 by Stewart L. Appelrouth and Carlos M. Farah. The firm's partners and professionals have experience in many areas of accounting and tax typically found only in national accounting firms. Appelrouth, Farah & Co. services the full spectrum of private and public sectors, business conditions, geographical locations and market conditions.

SEMA Insurance, based in Coral Gables, Florida, is a leading independent specialty broker with over 25 years of experience in providing innovative risk management solutions. The firm focuses on delivering comprehensive insurance programs tailored for the aviation, marine, and commercial sectors, ensuring clients receive a broad spectrum of coverage options. With a commitment to client-driven services, SEMA Insurance excels in identifying and quantifying risks while implementing customized strategies that enhance financial stability and security. The agency benefits from strong relationships with key trading partners globally, positioning itself as a competitive player against larger global broking firms. Generated from the website